Campbell Bradley L
Transaction: 04/27/2026
SELL
Change
-482,908
Price
$9.41
Filing
04/27/2026
Type
SELL
Amicus Therapeutics, Inc.
FOLD • Biotechnology
$14.49
— 0.00 (0.00%)
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$4.56B
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 16.3%Positive free cash flow · 0.1Healthy liquidity · 2.84Weak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Feb 20, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$14.49
Change0.00%
Shares Out314.36M
Market Cap$4.56B
Enterprise Value$4.70B
52W Range5.51 - 14.50
Beta0.48
P/E-168.02
P/S7.18
P/B16.61
P/FCF152.60
EV/Sales7.42
Price$14.49
Change0.00%
Shares Out314.36M
Market Cap$4.56B
Enterprise Value$4.70B
52W Range5.51 - 14.50
Beta0.48
P/E-168.02
P/S7.18
P/B16.61
P/FCF152.60
EV/Sales7.42
EV/EBITDA87.42
EV/FCF157.59
Earnings Yield-0.60%
FCF Yield0.66%
Dividend Yield0.00%
Gross Margin87.32%
Oper. Margin5.44%
Profit Margin-4.27%
Debt/Eq1.76
Current Ratio2.84
Quick Ratio1.88
Target$14.86
Target Upside2.55%
Target Median$14.50
Target Range13.00 - 19.00
Volume0.00
Avg Volume4.15M
EPS Surprise-0.06
Investment DNA
How strong this company looks for long-term investors
44
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
60/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
26/100
Why this score▼
Positive revenue growth · 16.3%Positive free cash flow · 0.1Healthy liquidity · 2.84Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 24 analyst votes · 2026-10-20
81/100
Bullish
Bullish
16
Hold
7
Bearish
1
Price Target
2026-06-05
Low
$14.50
Mean
$14.50
Median
$14.50
High
$14.50
Insider Transactions
Recent executive and insider activity
⚠ 12 high-volume insider sells detected
Campbell Bradley L
Transaction: 04/27/2026
SELL
Change
-1,008,680
Price
$14.50
Filing
04/27/2026
Type
SELL
Harford Simon N.R.
Transaction: 04/27/2026
SELL
Change
-150,517
Price
$9.41
Filing
04/27/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Campbell Bradley L | SELL | -482,908 | $9.41 | 04/27/2026 | 04/27/2026 |
| Campbell Bradley L | SELL | -1,008,680 | $14.50 | 04/27/2026 | 04/27/2026 |
| Harford Simon N.R. | SELL | -150,517 | $9.41 | 04/27/2026 | 04/27/2026 |
| Harford Simon N.R. | SELL | -143,595 | $14.50 | 04/27/2026 | 04/27/2026 |
| Rosenberg Ellen | SELL | -203,825 | $9.41 | 04/27/2026 | 04/27/2026 |
| Rosenberg Ellen | SELL | -15,000 | $14.50 | 04/27/2026 | 04/27/2026 |
| Clark David Michael | SELL | -125,430 | $9.41 | 04/27/2026 | 04/27/2026 |
| Clark David Michael | SELL | -221,811 | $14.50 | 04/27/2026 | 04/27/2026 |
| Castelli Jeff | SELL | -150,517 | $9.41 | 04/27/2026 | 04/27/2026 |
| Castelli Jeff | SELL | -427,089 | $14.50 | 04/27/2026 | 04/27/2026 |
| Prout Samantha | SELL | -62,715 | $9.41 | 04/27/2026 | 04/27/2026 |
| Prout Samantha | SELL | -125,951 | $14.50 | 04/27/2026 | 04/27/2026 |
| RAAB MICHAEL | SELL | -74,872 | $5.96 | 04/27/2026 | 04/27/2026 |
| RAAB MICHAEL | SELL | -115,857 | $14.50 | 04/27/2026 | 04/27/2026 |
| Kelly Michael Aaron | SELL | -74,872 | $5.96 | 04/27/2026 | 04/27/2026 |
| Kelly Michael Aaron | SELL | -72,468 | $14.50 | 04/27/2026 | 04/27/2026 |
| Bleil Lynn Dorsey | SELL | -74,872 | $5.96 | 04/27/2026 | 04/27/2026 |
| Bleil Lynn Dorsey | SELL | -113,941 | $14.50 | 04/27/2026 | 04/27/2026 |
| ROBERTS EIRY | SELL | -74,872 | $5.96 | 04/27/2026 | 04/27/2026 |
| ROBERTS EIRY | SELL | -76,275 | $14.50 | 04/27/2026 | 04/27/2026 |